- Home
- MCRB vs PPIH Comparison
MCRB vs PPIH Comparison
Compare MCRB & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- PPIH
- Stock Information
- Founded
- MCRB 2010
- PPIH 1993
- Country
- MCRB United States
- PPIH United States
- Employees
- MCRB N/A
- PPIH N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- PPIH Pollution Control Equipment
- Sector
- MCRB Health Care
- PPIH Industrials
- Exchange
- MCRB Nasdaq
- PPIH Nasdaq
- Market Cap
- MCRB 156.3M
- PPIH 128.3M
- IPO Year
- MCRB 2015
- PPIH N/A
- Fundamental
- Price
- MCRB $0.84
- PPIH $14.49
- Analyst Decision
- MCRB Buy
- PPIH
- Analyst Count
- MCRB 4
- PPIH 0
- Target Price
- MCRB $5.63
- PPIH N/A
- AVG Volume (30 Days)
- MCRB 2.4M
- PPIH 53.7K
- Earning Date
- MCRB 11-13-2024
- PPIH 12-23-2024
- Dividend Yield
- MCRB N/A
- PPIH N/A
- EPS Growth
- MCRB N/A
- PPIH 213.23
- EPS
- MCRB N/A
- PPIH 1.98
- Revenue
- MCRB $126,325,000.00
- PPIH $153,576,000.00
- Revenue This Year
- MCRB N/A
- PPIH N/A
- Revenue Next Year
- MCRB N/A
- PPIH N/A
- P/E Ratio
- MCRB N/A
- PPIH $7.55
- Revenue Growth
- MCRB 12856.41
- PPIH 4.52
- 52 Week Low
- MCRB $0.54
- PPIH $6.83
- 52 Week High
- MCRB $2.05
- PPIH $17.58
- Technical
- Relative Strength Index (RSI)
- MCRB 47.60
- PPIH 44.32
- Support Level
- MCRB $0.80
- PPIH $16.57
- Resistance Level
- MCRB $1.00
- PPIH $17.50
- Average True Range (ATR)
- MCRB 0.06
- PPIH 1.16
- MACD
- MCRB -0.01
- PPIH -0.16
- Stochastic Oscillator
- MCRB 20.46
- PPIH 33.11
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, Middle East, Europe, India and other countries.